South Florida Trim Clinic

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• SemaglutideType not stated
• TirzepatideType not stated
• NAD+Compounded · not FDA-approved

What they publish

South Florida Trim Clinic publishes 5 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

None — states no hidden fees and no membership charges (as published)

Medication cost

GLP-1 medication published as starting at $149 per month, stated to vary by medication type and potency, with exact pricing reviewed during a free consultation. NAD+ therapy advertised at $129 reduced from $149 (as published)

Introductory offer

Not publicly disclosed on the pages we captured.

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Free consultation with a real person before anything is recommended, followed by a licensed provider reviewing history and goals and prescribing if eligible.

Eligibility

States it serves eligible patients across 47 states from a base in Naples, Florida, and commits to telling patients when they do not qualify. Specific clinical criteria were not published on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

States medication ships from an FDA-regulated pharmacy. The pharmacy is not named, and the regulatory description is imprecise — the FDA registers outsourcing facilities but does not approve compounded preparations.

Shipping

States free shipping direct to your door from what it describes as an FDA-regulated pharmacy.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Cancellation terms were not published on the pages we captured.

Refunds

Refund terms were not published on the pages we captured.

What stands out

• Publishes a starting price and states openly that it varies by medication type and potency, rather than presenting $149 as a flat rate.
• States it will tell patients when they do not qualify, and describes its approach as consultation-first with no upsells.
• Frames weight as a medical issue and markets on a non-shaming approach rather than transformation imagery.
• Describes its pharmacy as 'FDA-regulated', which is loose phrasing: the FDA registers 503B outsourcing facilities and inspects them, but compounded preparations themselves are not FDA-approved, as the site does not state clearly.
• Serves 47 states from a small Florida base, so the in-person element implied by 'rooted in Naples' does not apply to most customers.
• Runs time-limited promotional pricing on adjacent products such as NAD+.
• No refund, cancellation, lab or eligibility criteria are published.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• $149 is a starting price that varies by medication and potency. What will your actual dose cost by month three?
• Is the medication compounded or branded? The site does not say, and 'FDA-regulated pharmacy' does not answer it.
• Which pharmacy dispenses, and is it a 503A or a 503B?
• No refund or cancellation terms are published. What applies if you stop?
• What clinical criteria are used, and is lab work required?

Frequently asked